Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage.
about
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understandingStructural imaging measures of brain aging.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2Development and validation of risk index for cognitive decline using blood-derived markersCerebrospinal fluid vascular endothelial growth factor.Cerebral Amyloid and Hypertension are Independently Associated with White Matter Lesions in Elderly.Positron Emission Tomographic Imaging in Stroke: Cross-Sectional and Follow-Up Assessment of Amyloid in Ischemic Stroke.Differential effects of ischemic vascular disease and Alzheimer's disease on brain atrophy and cognition.Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlifePrediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status.Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference
P2860
Q26801629-EF9CD8D7-28D9-4F5A-83D5-D97AA791D0D7Q26801640-25FFC617-B6D2-45F1-9E9A-D52F7A5B2F03Q30844186-F31318B7-8978-4E78-BAEF-C3EE5A893FC8Q30971403-1EA77296-7939-4D4E-81F0-10C763CCA42DQ30981669-F01371BA-E9D7-4CFD-BD00-531D45D6A79CQ35106599-E4DFC208-3F61-40E9-936F-81B1CE8B3761Q35650363-F4B24DC4-FEEF-4A01-9593-D980C4BE05E9Q36332727-5253AF31-6148-42D1-AA91-F3DFFCE4BCE4Q36398793-99398B70-2357-4E4F-A6E9-C5A65EEE51B4Q36593197-E92AE00C-C9E8-4466-8A89-2DB1221C0A7FQ37590021-6B9378C7-B9BD-4DE9-9717-973D67DC09CBQ38391075-C0357901-9DB2-49C9-B7E4-89648AC01BFDQ47604596-61512308-C9FC-447B-984D-CD08410816BAQ57464757-23334213-6D71-4153-8782-9BFED3AEBA78
P2860
Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Subgroup of ADNI normal contro ...... sociated with vascular damage.
@en
Subgroup of ADNI normal contro ...... sociated with vascular damage.
@nl
type
label
Subgroup of ADNI normal contro ...... sociated with vascular damage.
@en
Subgroup of ADNI normal contro ...... sociated with vascular damage.
@nl
prefLabel
Subgroup of ADNI normal contro ...... sociated with vascular damage.
@en
Subgroup of ADNI normal contro ...... sociated with vascular damage.
@nl
P2093
P2860
P356
P1433
P1476
Subgroup of ADNI normal contro ...... ssociated with vascular damage
@en
P2093
Charles Decarli
Evan Fletcher
Jasmine Nettiksimmons
Owen Carmichael
P2860
P304
P356
10.1037/A0031063
P577
2013-03-01T00:00:00Z